(Q44738594)

English

Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Guillain–Barré syndrome

0 references

methylprednisolone

1 reference

based on heuristic

inferred from title

author name string

R van Koningsveld

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

P I M Schmitz

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

F G Avander Meché

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

L H Visser

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

J Meulstee

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

P A van Doorn

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Dutch GBS study group

7

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

language of work or name

0 references

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

363

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

9404

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

192-196

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Epidemiological study of Guillain-Barré syndrome in south east England

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915324-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Mild forms of Guillain-Barré syndrome in an epidemiologic survey in The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915324-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Fatigue in immune-mediated polyneuropathies. European Inflammatory Neuropathy Cause and Treatment (INCAT) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915324-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Residual signs in severe Guillain-Barré syndrome: analysis of 57 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915324-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term outcome in patients with Guillain-Barré syndrome requiring mechanical ventilation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915324-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlled trial prednisolone in acute polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915324-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915324-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915324-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915324-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Preceding infections, immune factors, and outcome in Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915324-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915324-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915324-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study. The Dutch Guillain-Barré Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915324-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of current diagnostic criteria for Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915324-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915324-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barré Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915324-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915324-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915324-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Fulminant Guillain-Barré syndrome with universal inexcitability of peripheral nerves: a clinicopathological study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915324-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Rational therapy of Guillain-Barré syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915324-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(03)15324-X

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44738594&oldid=2035639156"